Ticker
PRTC
Analysis
Puretech Health Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PRTC.
Puretech Health Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PRTC.
PRTC
Stock
$417.9M
Health Technology
Biotechnology
GBX
Puretech Health Plc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
PureTech Health plc announced that its founded entity, Seaport Therapeutics, has reported positive multiple-ascending dose data from a Phase 1 trial of GlyphAgo™ (SPT-320) in he...
PureTech Health plc has announced a correction regarding a TR-1 notification of major holdings previously issued by Citigroup Inc. Shareholders are instructed to disregard the n...
PureTech Health plc announced that its deupirfenidone (LYT-100) program, being advanced by its Founded Entity Celea Therapeutics, will be showcased at the American Thoracic Soci...
PureTech Health plc announced that its founded entity, Seaport Therapeutics, has priced its upsized initial public offering of 14,160,000 shares at $18.00 per share, raising gro...
BOSTON, April 29, 2026--PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
Review valuation context for Puretech Health Plc.
Review future growth context for Puretech Health Plc.
Review past performance context for Puretech Health Plc.
Review financial health context for Puretech Health Plc.
Review dividend context for Puretech Health Plc.
Review management context for Puretech Health Plc.
Review ownership context for Puretech Health Plc.
Review other information context for Puretech Health Plc.
Review community context for Puretech Health Plc.